Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Aveo Oncology reports results of exploratory Phase 2 study of ficlatuzumab
Aveo Oncology reports results of exploratory Phase 2 study of ficlatuzumab
Aveo Oncology reports results of exploratory Phase 2 study of ficlatuzumab
Submitted by
admin
on October 1, 2012 - 10:41am
Source:
Yahoo/Fly on the Wall
News Tags:
Aveo Oncology
ficlatuzumab
gefitinib
non-small cell lung cancer
Headline:
Aveo Oncology reports results of exploratory Phase 2 study of ficlatuzumab
Do Not Allow Advertisers to Use My Personal information
